Procter & Gamble Hygiene and Health Care growth ratios

·FMCG & RetailChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY27Jun 2026FY26Jun 2025FY25Jun 2024FY23 and earlierAlpha Plus
−4.9%−77.7%+7.3%
FY23 and earlierEvery year the company has filed comes with Alpha Plus.
−36.1%−72.6%+11.7%
−37.6%−71.9%+12.8%
−34.3%−71.5%−0.5%
−34.3%−71.5%−0.5%
——−13.0%
——−18.1%
——−43.0%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

PGHH₹6,923.50

Procter & Gamble Hygiene and Health Care Limited

· FMCG & Retail
₹ CrorePeersBAJAJCONJHSMcap ₹22,474 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
30/06/2023
FY25
30/06/2024
FY26
30/06/2025
FY27
30/06/2026
Revenue Growth—+7.3-77.7-4.9
EBITDA Growth—+11.7-72.6-36.1
EBIT Growth—+12.8-71.9-37.6
Net Income Growth—-0.5-71.5-34.3
EPS Growth—-0.5-71.5-34.3
Total Assets Growth—-13.0——
Total Equity Growth—-18.1——
Cash from Operations Growth—-43.0——
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY27 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.